The global Contract Research Organization (CRO) Services Market is expected to reach USD 91.2 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 8.2% from 2021 to 2030. The growth of the market is attributed to the increasing demand for cost-effective drug development services, the rising prevalence of chronic diseases, and the growing number of clinical trials.
The increasing demand for personalized medicine and the growing focus on drug safety and efficacy are also expected to drive the market growth. The increasing number of mergers and acquisitions among CRO`s is also expected to contribute to the growth of the market. Furthermore, the increasing adoption of advanced technologies such as artificial intelligence (AI) and machine learning (ML) is expected to create lucrative opportunities for the market.
The market is segmented based on service type, therapeutic area, end-user, and region. By service type, the market is divided into preclinical services, clinical trial services, and post-approval services. The clinical trial services segment is expected to dominate the market during the forecast period due to the increasing number of clinical trials and the rising demand for cost-effective drug development services.
By therapeutic area, the market is divided into oncology, neurology, cardiovascular diseases, infectious diseases, and others. The oncology segment is expected to dominate the market during the forecast period due to the increasing prevalence of cancer and the rising demand for personalized medicine.
By end-user, the market is divided into pharmaceutical and biotechnology companies, medical device companies, and academic and research institutes. The pharmaceutical and biotechnology companies segment is expected to dominate the market during the forecast period due to the increasing number of clinical trials and the rising demand for cost-effective drug development services.
Regionally, the market is divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to dominate the market during the forecast period due to the presence of a large number of Contract Research Organization in the region and the increasing demand for personalized medicine.
The key players in the market include Parexel International Corporation, IQVIA Holdings Inc., Covance Inc., Syneos Health Inc., Charles River Laboratories International Inc., ICON plc, PRA Health Sciences Inc., Wuxi AppTec Co., Ltd., Pharmaceutical Product Development LLC (PPD), VIal CRO and Clinipace Worldwide. These players are focusing on strategies such as mergers and acquisitions, collaborations, and product launches to gain a competitive edge in the market.
Comments
Post a Comment